GoodRx To Offer $35 Sanofi Insulin Injection

Americans with a prescription for Lantus-branded insulin, regardless of insurance status, can now get the life-saving drug for only $35.

Healthcare company GoodRx announced Thursday a partnership with the pharmaceutical firm Sanofi to offer $35 coupons for a 30-day supply of Lantus.

"Efforts to make insulin more accessible have been at the forefront of the news for months, and a critical piece of delivering on this promise is making it as simple as possible for patients to get the lower price right at their regular pharmacy counter,” said Dorothy Gemmell, chief commercial officer at GoodRx, in a statement.

Patients can now visit GoodRx.com/lantus to access the coupon, which is redeemable at 70,000 pharmacy locations, including Walgreens, CVS and Walmart.

“Sanofi believes that no one should struggle to pay for their insulin,” said Head of U.S. General Medicines Olivier Bogillot in a statement.

Earlier this year, Sanofi announced it was cutting the U.S. list price of Lantus by 78%, to $35, for patients with commercial insurance. This price change goes into effect Jan. 1. Novo Nordisk and Eli Lilly have made similar price cuts.

In 2019, about 37.3 million Americans — about 11% of the population — had diabetes, according to the American Diabetes Association.